Member Info for Sangijuelas1

Porky please stop lying about funding.

The company is not fully funded into 2023.

They have cash until maybe October.

The annual report states clearly they need to raise almost half the market cap.

You believe that Oxford will come through. I don't. All they have provided is $5m so far.

The other $7.5m from the initial loan has had to be locked up in a custodian bank account in the US.

The condition for its use was a $45m raise by the 1st April which didn't happen.

All of this is in the annual report. So I prefer to go by that rather than your ramblings.

You see Oxford as like a charity or a magic money tree. I disagree on that point.

If you don't want "derampers" try and stick to the facts.

Like any good cult they tell you not to listen to anyone asking questions.

Just filter them and everything will be OK if you just listen to the cult leaders

@Taunton Boy
#washtrading

With @Porky9 and @soundsrisky

But all 3 of you use it and you all claim to be making large repeated buys.

I just skimmed through 10 pages of posts on Avacta and came across 1 poster using @ out of the dozens that post there.

It's too much of a coincidence for my liking. We all know the lengths Porky has gone to to ramp this share.

I am entitled to believe what I want on the basis of probabilities.

Oh wait wait. The @ is used by Porky9 a lot as well.

The plot thickens

"RE: 4D - Onwards and Upwards25 Apr 2022 03:09
@CrustyPete
Beat to it by @soundsrisky but Duncan sounded confident. We are also past that 1/4/22 milestone date so I think every chance of an update from Duncan regarding Oxford Finance not to mention other matters fairly soon. At least with everyone returning back this week volumes should hopefully start picking back up.
GLA"

The @ gave you away. No one else uses it.

And yet Taunton (new account 01/04) and Sounds Risky both deploy @ whenever they address someone.

How strange

I am calling out you and Taunton Boy.

I have said nothing good or bad about 4D today.

Strange when Oliveira was selling 1% a month it caused the SP to drop continuously and yet you claim to be buying 1% a month but price keeps dropping

Yeah I was looking through your posting. Weird how you pick a stock and then post relentlessly on it and nothing else for a few weeks and then disappear.

A bit like Rocket79

Maybe you are buying and selling from yourself?

As in wash trades. Who knows?

Funny how you and Sounds Risky both use the @ symbol a lot in your posts.

Just a coincidence I am sure.

And both of you have only posted on 4D these last few weeks.

Your account is a completely new one Taunton Boy.

Given that we are all anonymous here it's sometimes good to be a bit wary.

We have had a few pumper dumpers on this stock over the last 2-3 years.

Hi Sounds Risky, are you Wigscoff 88 or Rocket79.

Same MO

How are EUA, Evraz and Amigo going? Surprised you have any funds left after those?

You aren't alone.

I have been rebuilding a position here. With the long term in mind.

I imagine there has been a bit of an impact as I think near term IPOs will be much harder for exits and also maybe some of the valuations that make up the NAV are likely to be revised down.

Not really concerned by that as just see future value being stored up. I am not a fan of premature exits for an early profit when some of the companies have much further to go.

Couple more links from the work being done at University of Leicester by Prof Brightling and others, which mention £50m funding so far for Long Covid research and treatment.

https://le.ac.uk/news/2021/december/phosp-12-months

https://le.ac.uk/research/stories/human-health/covid-rehab

I think it is possible that 4Ds asthma drug, the Parkinsons candidates and Blautix could all play a potential role as treatments.

In the clinical adviser article I linked to they said Long Covid patients have deficiencies of bifidobacterium (Mrx 0004 asthma), blautia (Blautix) and butyrate producing microbes (the Parkinsons drugs).

Obviously speculation on my part about future areas of research but the involvement of Chris Brightling is at least a link to 4D.

I have been finding links to gut microbiome and Long Covid for a while now. It is going to be a big problem as per this FT article
https://www.ft.com/content/e62008ff-bebf-4f9f-bc3a-9bb54991fc30

May turn out to be something that needs government support and funding.

One reason I still have some belief that 4D could be a successful company is the future possibility that live biotherapeutics could turn out to be a treatment for Long Covid.

https://www.clinicaladvisor.com/home/topics/gastroenterology-information-center/long-haul-covid-19-linked-altered-microbiome/

In this vein, it was interesting to see the lead investigator on the 4D asthma trial, Chris Brightling, quoted in this article on Long Covid this morning.

https://www.theguardian.com/world/2022/apr/24/only-29-of-uk-covid-hospital-patients-recover-within-a-year

Well that's what they are trying to do in combination with Keytruda.
Obviously the key is doing it in such a way to be able to get enough t cells attacking the cancer to get some reduction.
Clearly not an easy task in patients with such advanced cancer and aggressive tumours.

Just hope can secure funding to be able to take all the programs forward

Of a T cell attacking a cancer cell

This is what 0518 stimulates the immune system to do

https://mobile.twitter.com/RitterLab/status/1516778400614010887?cxt=HHwWjsCquen61owqAAAA

I was aware of that. I just hoped for more responses from Part B given there were 2 from 9 in Part A.

Approval would be based on responders with tumour shrinkage or stable disease with improved overall survival. The latter would take a lot longer to collect data

Phil it's also about getting insurers in the US or Nice in the UK to pay out for Keytruda when the only efficacy data is for stable disease with little chance of a response.

I imagine 4D expected to at least replicate or improve on the Part A results.

I am trying to make an educated guess and not be biased because of what I want to happen or what I want to be true